Suh CO - Search Results

1

MGMT gene promoter methylation as a potent prognostic factor in glioblastoma treated with temozolomide-based chemoradiotherapy: a single-institution study.

Kim YS, Kim SH, Cho J, Kim JW, Chang JH, Kim DS, Lee KS, Suh CO. Kim YS, et al. Among authors: suh co. Int J Radiat Oncol Biol Phys. 2012 Nov 1;84(3):661-7. doi: 10.1016/j.ijrobp.2011.12.086. Epub 2012 Mar 11. Int J Radiat Oncol Biol Phys. 2012. PMID: 22414280

2

Dose optimization of fractionated external radiation and high-dose-rate intracavitary brachytherapy for FIGO stage IB uterine cervical carcinoma.

Lee SW, Suh CO, Chung EJ, Kim GE. Lee SW, et al. Among authors: suh co. Int J Radiat Oncol Biol Phys. 2002 Apr 1;52(5):1338-44. doi: 10.1016/s0360-3016(01)02821-8. Int J Radiat Oncol Biol Phys. 2002. PMID: 11955747

3

Role of radiotherapy for primary orbital lymphoma.

Lee SW, Suh CO, Kim GE, Yang WI, Lee SY, Hahn JS, Park JO. Lee SW, et al. Among authors: suh co. Am J Clin Oncol. 2002 Jun;25(3):261-5. doi: 10.1097/00000421-200206000-00011. Am J Clin Oncol. 2002. PMID: 12040284

4

Dose-response relationship in local radiotherapy for hepatocellular carcinoma.

Park HC, Seong J, Han KH, Chon CY, Moon YM, Suh CO. Park HC, et al. Among authors: suh co. Int J Radiat Oncol Biol Phys. 2002 Sep 1;54(1):150-5. doi: 10.1016/s0360-3016(02)02864-x. Int J Radiat Oncol Biol Phys. 2002. PMID: 12182985

5

Radiation treatment for aggressive fibromatosis: findings from observed patterns of local failure.

Park HC, Pyo HR, Shin KH, Suh CO. Park HC, et al. Among authors: suh co. Oncology. 2003;64(4):346-52. doi: 10.1159/000070292. Oncology. 2003. PMID: 12759531

6

Combination of external beam irradiation and high-dose-rate intraluminal brachytherapy for inoperable carcinoma of the extrahepatic bile ducts.

Shin HS, Seong J, Kim WC, Lee HS, Moon SR, Lee IJ, Lee KK, Park KR, Suh CO, Kim GE. Shin HS, et al. Among authors: suh co. Int J Radiat Oncol Biol Phys. 2003 Sep 1;57(1):105-12. doi: 10.1016/s0360-3016(03)00410-3. Int J Radiat Oncol Biol Phys. 2003. PMID: 12909222 Clinical Trial.

7

Rationale for radiotherapy as a treatment modality in gastric mucosa-associated lymphoid tissue lymphoma.

Park W, Chang SK, Yang WI, Ko YH, Huh SJ, Ahn YC, Suh CO. Park W, et al. Among authors: suh co. Int J Radiat Oncol Biol Phys. 2004 Apr 1;58(5):1480-6. doi: 10.1016/j.ijrobp.2003.09.002. Int J Radiat Oncol Biol Phys. 2004. PMID: 15050327

8

Angiocentric T-cell and NK/T-cell lymphomas: radiotherapeutic viewpoints.

Koom WS, Chung EJ, Yang WI, Shim SJ, Suh CO, Roh JK, Yoon JH, Kim GE. Koom WS, et al. Among authors: suh co. Int J Radiat Oncol Biol Phys. 2004 Jul 15;59(4):1127-37. doi: 10.1016/j.ijrobp.2003.12.006. Int J Radiat Oncol Biol Phys. 2004. PMID: 15234048

9

Differential cyclooxygenase-2 expression in squamous cell carcinoma and adenocarcinoma of the uterine cervix.

Kim YB, Kim GE, Pyo HR, Cho NH, Keum KC, Lee CG, Seong J, Suh CO, Park TK. Kim YB, et al. Among authors: suh co. Int J Radiat Oncol Biol Phys. 2004 Nov 1;60(3):822-9. doi: 10.1016/j.ijrobp.2004.04.030. Int J Radiat Oncol Biol Phys. 2004. PMID: 15465199

10

Coexpression of cyclooxygenase-2 and thymidine phosphorylase as a prognostic indicator in patients with FIGO stage IIB squamous cell carcinoma of uterine cervix treated with radiotherapy and concurrent chemotherapy.

Pyo H, Kim YB, Cho NH, Suh CO, Park TK, Yun YS, Kim GE. Pyo H, et al. Among authors: suh co. Int J Radiat Oncol Biol Phys. 2005 Jul 1;62(3):725-32. doi: 10.1016/j.ijrobp.2004.10.044. Int J Radiat Oncol Biol Phys. 2005. PMID: 15936552

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

220 results

Search Page

Filters